Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melioidosis.

Sharon J Peacock1

  • 1Wellcome Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. sharon@tropmedres.ac

Current Opinion in Infectious Diseases
|August 31, 2006
PubMed
Summary
This summary is machine-generated.

Melioidosis remains a global health threat with high mortality. Current research focuses on patient management, risk factors, and diagnosis, but affordable interventions to reduce death rates are urgently needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR-based environmental detection of Burkholderia pseudomallei identifies sanitation gaps and melioidosis risk in northeast Thailand.

Nature communications·2026
Same author

Whole-genome sequencing to investigate the prevalence and transmission of multidrug-resistant Gram-negative pathogens in an adult intensive care unit in the UK.

Microbial genomics·2026
Same author

BaGPipe: an automated, reproducible, and flexible pipeline for bacterial genome-wide association studies.

BMC microbiology·2026
Same author

Transitioning to people-centred antimicrobial resistance surveillance.

The Lancet. Infectious diseases·2025
Same author

Large-scale characterisation of the nasal microbiome redefines Staphylococcus aureus colonisation status.

Nature communications·2025
Same author

Whole genome sequencing reveals novel resistance-conferring mutations and large genome deletions in drug-resistant Mycobacterium tuberculosis isolates from Indonesia.

Journal of global antimicrobial resistance·2025
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Public Health

Background:

  • Melioidosis is a globally emerging infectious disease with persistently high mortality rates.
  • Despite extensive research, effective strategies to reduce melioidosis-related deaths are lacking.
  • Patient management, including risk stratification, diagnosis, and treatment, is crucial for improving outcomes.

Purpose of the Study:

  • To review current literature on patient management strategies for melioidosis.
  • To identify risk factors, diagnostic methods, and therapeutic approaches for melioidosis.
  • To summarize advancements in genomics, immunology, and pathogenesis of melioidosis.

Main Methods:

  • Systematic review of clinical studies on melioidosis patient management.

Related Experiment Videos

  • Evaluation of microbiological techniques and polymerase chain reaction for bacterial identification.
  • Analysis of antimicrobial therapy trials and outcome prediction studies.

    • Main Results:

    • Tsunami involvement is a risk factor; risk may extend to bystanders.
    • Standard microbiological techniques and PCR for Burkholderia pseudomallei identification were assessed.
    • Antimicrobial therapy trials offer evidence for refining treatment protocols; predictors of poor outcome identified.

    Conclusions:

    • No reviewed studies report mortality-reducing strategies for melioidosis.
    • Future research must focus on affordable, low-resource interventions to decrease melioidosis mortality.
    • Development of effective vaccines remains a distant prospect.